Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

377 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mepolizumab and exacerbations of refractory eosinophilic asthma.
Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, Marshall RP, Bradding P, Green RH, Wardlaw AJ, Pavord ID. Haldar P, et al. N Engl J Med. 2009 Mar 5;360(10):973-84. doi: 10.1056/NEJMoa0808991. N Engl J Med. 2009. PMID: 19264686 Free PMC article. Clinical Trial.
Airway wall geometry in asthma and nonasthmatic eosinophilic bronchitis.
Siddiqui S, Gupta S, Cruse G, Haldar P, Entwisle J, Mcdonald S, Whithers PJ, Hainsworth SV, Coxson HO, Brightling C. Siddiqui S, et al. Among authors: haldar p. Allergy. 2009 Jun;64(6):951-8. doi: 10.1111/j.1398-9995.2009.01951.x. Epub 2009 Feb 11. Allergy. 2009. PMID: 19210350 Free PMC article.
Mepolizumab in refractory eosinophilic asthma.
Pavord ID, Haldar P, Bradding P, Wardlaw AJ. Pavord ID, et al. Among authors: haldar p. Thorax. 2010 Apr;65(4):370. doi: 10.1136/thx.2009.122697. Thorax. 2010. PMID: 20388767 No abstract available.
Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.
Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, McCormick M, Haldar K, Kebadze T, Duvoix A, Lindblad K, Patel H, Rugman P, Dodson P, Jenkins M, Saunders M, Newbold P, Green RH, Venge P, Lomas DA, Barer MR, Johnston SL, Pavord ID, Brightling CE. Bafadhel M, et al. Among authors: haldar p, haldar k. Am J Respir Crit Care Med. 2011 Sep 15;184(6):662-71. doi: 10.1164/rccm.201104-0597OC. Am J Respir Crit Care Med. 2011. PMID: 21680942
Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthma.
Desai D, Newby C, Symon FA, Haldar P, Shah S, Gupta S, Bafadhel M, Singapuri A, Siddiqui S, Woods J, Herath A, Anderson IK, Bradding P, Green R, Kulkarni N, Pavord I, Marshall RP, Sousa AR, May RD, Wardlaw AJ, Brightling CE. Desai D, et al. Among authors: haldar p. Am J Respir Crit Care Med. 2013 Sep 15;188(6):657-63. doi: 10.1164/rccm.201208-1470OC. Am J Respir Crit Care Med. 2013. PMID: 23590263 Free PMC article.
Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study).
Agbetile J, Bourne M, Fairs A, Hargadon B, Desai D, Broad C, Morley J, Bradding P, Brightling CE, Green RH, Haldar P, Pashley CH, Pavord ID, Wardlaw AJ. Agbetile J, et al. Among authors: haldar p. J Allergy Clin Immunol. 2014 Jul;134(1):33-9. doi: 10.1016/j.jaci.2013.09.050. Epub 2013 Nov 28. J Allergy Clin Immunol. 2014. PMID: 24290286 Clinical Trial.
Responsiveness to oral prednisolone in severe asthma is related to the degree of eosinophilic airway inflammation.
Sousa AR, Marshall RP, Warnock LC, Bolton S, Hastie A, Symon F, Hargadon B, Marshall H, Richardson M, Brightling CE, Haldar P, Milone R, Chalk P, Williamson R, Panettieri R Jr, Knowles R, Bleecker ER, Wardlaw AJ. Sousa AR, et al. Among authors: haldar p. Clin Exp Allergy. 2017 Jul;47(7):890-899. doi: 10.1111/cea.12954. Epub 2017 Jun 16. Clin Exp Allergy. 2017. PMID: 28493293
377 results